Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure

Gregory De Lissovoy; David M. Stier; Gabrielle Ciesla; Mark Munger; Andrew J. Burger

doi:10.1016/S0002-9149(03)00742-2

Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure

Gregory De Lissovoy, David M. Stier, Gabrielle Ciesla, Mark Munger, Andrew J. Burger

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Abstract

Pooled data from trials comparing nesiritide with dobutamine for treatment of acute decompensated congestive heart failure were combined with national hospital cost data in an economic model. Results indicate that the acquisition cost of nesiritide is fully offset by decreased hospital costs.

Original language	English (US)
Pages (from-to)	631-633
Number of pages	3
Journal	The American Journal of Cardiology
Volume	92
Issue number	5
DOIs	https://doi.org/10.1016/S0002-9149(03)00742-2
State	Published - Aug 22 2003
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/S0002-9149(03)00742-2

Cite this

@article{ac016a58c396413fa6c163e91022048b,

title = "Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure",

abstract = "Pooled data from trials comparing nesiritide with dobutamine for treatment of acute decompensated congestive heart failure were combined with national hospital cost data in an economic model. Results indicate that the acquisition cost of nesiritide is fully offset by decreased hospital costs.",

author = "{De Lissovoy}, Gregory and Stier, {David M.} and Gabrielle Ciesla and Mark Munger and Burger, {Andrew J.}",

year = "2003",

month = aug,

day = "22",

doi = "10.1016/S0002-9149(03)00742-2",

language = "English (US)",

volume = "92",

pages = "631--633",

journal = "The American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure

AU - De Lissovoy, Gregory

AU - Stier, David M.

AU - Ciesla, Gabrielle

AU - Munger, Mark

AU - Burger, Andrew J.

PY - 2003/8/22

Y1 - 2003/8/22

N2 - Pooled data from trials comparing nesiritide with dobutamine for treatment of acute decompensated congestive heart failure were combined with national hospital cost data in an economic model. Results indicate that the acquisition cost of nesiritide is fully offset by decreased hospital costs.

AB - Pooled data from trials comparing nesiritide with dobutamine for treatment of acute decompensated congestive heart failure were combined with national hospital cost data in an economic model. Results indicate that the acquisition cost of nesiritide is fully offset by decreased hospital costs.

UR - http://www.scopus.com/inward/record.url?scp=0041508542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041508542&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(03)00742-2

DO - 10.1016/S0002-9149(03)00742-2

M3 - Article

C2 - 12943895

AN - SCOPUS:0041508542

SN - 0002-9149

VL - 92

SP - 631

EP - 633

JO - The American Journal of Cardiology

JF - The American Journal of Cardiology

IS - 5

ER -

Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this